Purchase Order N0025922P0099
Award Date
2/17/22
Potential Completion Date
9/30/23
Potential Value
$745K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Bureau of Medicine and Surgery
Awardee
Gen-Probe Incorporated
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DOD) awarded a $357,330 firm fixed price purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide 95 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 28 Aptima SARS-CoV-2 control boxes containing 5 positive and 5 negative controls per box, and 20 Fusion specimen lysis tubes containing 100 bags per box. The place of performance is Marlborough, Massachusetts and the period of performance is from January 24, 2022...
<p>The Defense Health Agency awarded a $402,125 firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide APTIMA SARS-COV-2 ASSAY, EUA APTIMA CONTROLS, FUSION SPECIMEN LYSIS, AND PANTHER RUN KIT products and services. The place of performance will be in Marlborough, Massachusetts over a period starting July 20, 2022 and ending September 29, 2022 to support the agency's Coronavirus COVID-19 National Interest Action.</p>
The Defense Health Agency (DOD) awarded a $320,542.72 delivery order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY, EUA, 250-TEST. The firm fixed price contract has a period of performance starting on January 20, 2022 through February 18, 2022 and will be performed in Portsmouth, Virginia. Gen-Probe Incorporated will provide its APTIMA SARS-COV-2 ASSAY test kits, which have received Emergency Use Authorization from the U.S. Food and...
<p>The Defense Health Agency (DOD) awarded a $745,185 purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY KITS. The firm fixed price contract will provide coronavirus COVID-19 testing kits to support national interest actions in Japan, with performance taking place from May 10, 2022 through June 1, 2022.</p>
This firm fixed-price purchase order was awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of 250 APTIMA SARS-CoV-2 assay test kits, 30 APTIMA SARS-CoV-2 controls, and 76 Fusion specimen lysis tubes. The total potential value of the award is $239,790.00. The purchase order was not set aside and supports the government's Coronavirus COVID-19 response efforts. Gen-Probe Incorporated is a provider of molecular diagnostic testing...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
The Defense Health Agency (DOD) awarded a $339,005 purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide COVID-19 test kits and supplies. The place of performance is Bethesda, Maryland and the contract period is from January 28, 2022 to February 10, 2022. The pricing structure is firm fixed price. Gen-Probe Incorporated will supply coronavirus disease 2019 test kits and related materials to the Defense Health Agency to support continued testing...
This is a $249,560.00 firm fixed-price purchase order contract awarded by the Defense Health Agency to Gen-Probe Incorporated for the APTIMA SARS-COV-2 ASSAY. The contract has a completion date of May 12, 2022 and was awarded on February 11, 2022. Gen-Probe is a medical diagnostics company that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government. The company has held numerous contracts with defense and civilian agencies...
The Defense Health Agency (DOD) awarded a $888,380 firm fixed price delivery order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. for COVID19 reagents. The contract has a period of performance from November 17, 2020 through March 12, 2021, with all work to be conducted by the prime contractor at its location in Marlborough, Massachusetts. This delivery order is likely associated with DHA's medical products procurement programs to support the COVID-19 response effort. No...
The Defense Health Agency awarded a $2,300 firm fixed price delivery order contract to Gen-Probe Incorporated for COVID19 reagents. The contract has no set aside designation and requires performance in Marlborough, Massachusetts by March 23, 2021. Gen-Probe Sales & Service, Inc. will perform as a division of Gen-Probe Incorporated. The contract was awarded on March 16, 2021 under the National Interest Action Code for Coronavirus COVID-19 in support of the Defense Health Agency's response...